| abstract |
Variations in certain genomic sequences useful as genetic markers of Sudden Cardiac Death ('SCD'), or Sudden Cardiac Arrest ('SCA') risk, are described. Novel diagnostic kits and methods employing these genetic markers are used in assessing the risk of SCD, or SCA. Methods of distinguishing patients having an increased susceptibility to SCD, or SCA, through use of these markers, alone or in combination with other markers, are also provided. Further, methods of assessing the need for an Implantable Cardio Defibrillators ('ICD') in a patient are taught. |